Status:

TERMINATED

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial

Lead Sponsor:

State University of New York - Upstate Medical University

Collaborating Sponsors:

US Department of Veterans Affairs

Conditions:

Alcohol Dependence

Veterans

Eligibility:

All Genders

18-69 years

Phase:

PHASE4

Brief Summary

The goal of the proposed project is to improve the primary care treatment of veterans with alcohol dependence. Alcohol dependence is a common behavioral health problem among veterans treated in VA pri...

Eligibility Criteria

Inclusion

  • Participants must be males or non-pregnant females between the ages of 18 and 69 who are receiving their primary medical care at the Syracuse VAMC.
  • Participants must meet DSM-IV diagnostic criteria for current alcohol dependence.
  • Participants must report drinking within the thirty days prior to study entry.
  • Participants must receive approval from their primary care provider for study participation.
  • Participants must be willing to consider accepting at least one of the two treatment conditions.

Exclusion

  • Participants with a current DSM-IV diagnosis of current opioid abuse or dependence, or in opioid withdrawal
  • AST level is greater than 3 times the upper limit of the normal range
  • Participants with a medical condition requiring opioid medication or a severe allergy to naltrexone
  • Participants who received outpatient treatment at the Syracuse VA Chemical Dependence Clinic in the past 90 days
  • Any unstable medical or psychiatric conditions in the judgment of the principal investigator or the participants primary care provider

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00461890

Start Date

October 1 2006

End Date

December 1 2007

Last Update

October 24 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Syracuse VAMC

Syracuse, New York, United States, 13210

Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial | DecenTrialz